BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
BioCardia (Nasdaq: BCDA) will participate virtually in a fireside chat at the A.G.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
BioCardia (Nasdaq: BCDA) will participate virtually in a fireside chat at the A.G.P. Healthcare Company Showcase.
Timing: 11:40 AM ET on Wednesday, May 20, 2026. According to BioCardia, investors can register for the conference and view the session online.
Details
News Market Reaction – BCDA
On May 19, the day this news came out, BCDA closed 5.64% above the previous close.
Data tracked by StockTitan Argus for the May 19 session.
Key Figures
- Fireside chat time
- 11:40 AM ET
- Scheduled time for A.G.P. Healthcare Company Showcase fireside chat
- Fireside chat date
- May 20, 2026
- Scheduled date for A.G.P. Healthcare Company Showcase participation
Historical Context
-
Reported narrower net loss and supportive regulatory feedback for core programs.
-
Announced timing and access details for Q1 2026 results call.
-
FDA agreed on Helix catheter clearance pathways with no major safety concerns.
-
Announced allowance of Japanese patent for Heart3D Fusion Imaging software.
-
PMDA found CardiAMP data likely sufficient to support Japan market clearance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase.
Fireside Chat Details:
- Time: 11:40 AM ET
- Date: Wednesday, May 20, 2026
Investors can register for the conference and view the fireside chat here.
About BioCardia®
BioCardia, Inc., headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms. For more information visit: www.BioCardia.com.
Media Contact: Miranda Peto, Investor Relations Email: mpeto@BioCardia.com Phone: 650-226-0120 Investor Contact: David McClung, Chief Financial Officer Email: investors@BioCardia.com Phone: 650-226-0120
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.